Ozaki A - Search Results

1

Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.

Murayama A, Saito H, Kamamoto S, Shigeta H, Yamashita E, Tanimoto T, Ozaki A. Murayama A, et al. Among authors: ozaki a. Int Urogynecol J. 2023 Jun;34(6):1285-1292. doi: 10.1007/s00192-023-05463-y. Epub 2023 Feb 1. Int Urogynecol J. 2023. PMID: 36723634

2

Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States.

Murayama A, Kamamoto S, Shigeta H, Ozaki A. Murayama A, et al. Among authors: ozaki a. CJC Open. 2023 Mar;5(3):253-255. doi: 10.1016/j.cjco.2023.01.001. Epub 2023 Jan 5. CJC Open. 2023. PMID: 36624880 Free PMC article.

3

Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic.

Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A. Murayama A, et al. Among authors: ozaki a. Cureus. 2022 Dec 17;14(12):e32643. doi: 10.7759/cureus.32643. eCollection 2022 Dec. Cureus. 2022. PMID: 36654586 Free PMC article.

4

Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019.

Murayama A, Mamada H, Shigeta H, Yoshinaga T, Saito H, Yamashita E, Tanimoto T, Ozaki A. Murayama A, et al. Among authors: ozaki a. J Clin Rheumatol. 2023 Apr 1;29(3):118-125. doi: 10.1097/RHU.0000000000001922. Epub 2022 Dec 7. J Clin Rheumatol. 2023. PMID: 36729793

5

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.

Ozieranski P, Saito H, Rickard E, Mulinari S, Ozaki A. Ozieranski P, et al. Among authors: ozaki a. Global Health. 2023 Mar 3;19(1):14. doi: 10.1186/s12992-022-00902-9. Global Health. 2023. PMID: 36869318 Free PMC article.

6

Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021.

Shigeta H, Murayama A, Kamamoto S, Saito H, Ozaki A. Shigeta H, et al. Among authors: ozaki a. Cureus. 2023 Mar 23;15(3):e36567. doi: 10.7759/cureus.36567. eCollection 2023 Mar. Cureus. 2023. PMID: 37095789 Free PMC article.

7

Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States.

Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A. Murayama A, et al. Among authors: ozaki a. JMA J. 2023 Apr 14;6(2):201-203. doi: 10.31662/jmaj.2022-0210. Epub 2023 Mar 6. JMA J. 2023. PMID: 37179719 Free PMC article. No abstract available.

8

Rethinking Japan's Infallibility Principle for a Better Pandemic Response.

Kaneda Y, Ozaki A, Tanimoto T. Kaneda Y, et al. Among authors: ozaki a. Cureus. 2023 May 20;15(5):e39270. doi: 10.7759/cureus.39270. eCollection 2023 May. Cureus. 2023. PMID: 37378102 Free PMC article.

9

Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019.

Kamamoto S, Ozaki A, Murayama A. Kamamoto S, et al. Among authors: ozaki a. Cureus. 2023 Aug 17;15(8):e43633. doi: 10.7759/cureus.43633. eCollection 2023 Aug. Cureus. 2023. PMID: 37719565 Free PMC article.

10

Collateral damage from accelerated drug approval.

Ozaki A, Gonda K, Kaneda Y, Tanimoto T. Ozaki A, et al. Nature. 2023 Oct;622(7982):242. doi: 10.1038/d41586-023-03139-7. Nature. 2023. PMID: 37817035 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

776 results

Search Page

Filters